NewsBenzinga벨라이트 바이오, 스타가르트병 1형 치료제 틴라레반트의 싱가포르·영국·스위스 허가 신청서 제출 벨라이트 바이오, 스타가르트병 1형 치료제 틴라레반트의 싱가포르·영국·스위스 허가 신청서 제출 Benzinga 2026.10.14 20:04 (GMT+0) Open on Benzinga Other news PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17 What to Expect From Advanced Micro Devices’ Q3 2026 Earnings Report Here's What to Expect From Uber’s Next Earnings Report Aflac’s Q3 2026 Earnings: What to Expect Marathon Petroleum Earnings Preview: What to Expect American International Group’s Quarterly Earnings Preview: What You Need to Know
PDS Biotechnology Corporation (PDSB) Discusses PDS-0301 Immunocytokine and Its Role in Treating Metastatic Colorectal Cancer - Slideshow (NASDAQ:PDSB) 2026-10-17
